British Columbia Investment Management Corp Eli Lilly & CO Transaction History

British Columbia Investment Management Corp

$16 Billion
Q3 2024

A detailed history of British Columbia Investment Management Corp transactions in Eli Lilly & CO stock. As of the latest transaction made, British Columbia Investment Management Corp holds 141,635 shares of LLY stock, worth $112 Million. This represents 0.78% of its overall portfolio holdings.

Number of Shares

141,635

Previous 166,967 15.17%

Holding current value

$112 Million

Previous $151 Million 16.99%

% of portfolio

0.78%

Previous 0.94%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$772.14 - $960.02 $19.6 Million - $24.3 Million	-25,332 Reduced 15.17%	141,635 $125 Million
Q2 2024 Aug 14, 2024	BUY	$724.87 - $909.04 $40.8 Million - $51.1 Million	56,234 Added 50.78%	166,967 $151 Million
Q1 2024 May 14, 2024	BUY	$592.2 - $792.28 $10.6 Million - $14.1 Million	17,847 Added 19.21%	110,733 $86.1 Million
Q4 2023 Feb 14, 2024	BUY	$525.19 - $619.13 $10.2 Million - $12.1 Million	19,478 Added 26.53%	92,886 $54.1 Million
Q3 2023 Nov 14, 2023	BUY	$434.7 - $599.3 $148,667 - $204,960	342 Added 0.47%	73,408 $39.4 Million
Q2 2023 Aug 11, 2023	BUY	$350.74 - $468.98 $297,076 - $397,226	847 Added 1.17%	73,066 $34.3 Million
Q1 2023 May 12, 2023	BUY	$310.63 - $364.82 $169,914 - $199,556	547 Added 0.76%	72,219 $24.8 Million
Q4 2022 Feb 10, 2023	SELL	$321.55 - $374.67 $2.69 Million - $3.13 Million	-8,361 Reduced 10.45%	71,672 $26.2 Million
Q3 2022 Nov 10, 2022	SELL	$296.48 - $337.87 $4.15 Million - $4.73 Million	-14,012 Reduced 14.9%	80,033 $25.9 Million
Q2 2022 Aug 12, 2022	SELL	$278.73 - $327.27 $8.83 Million - $10.4 Million	-31,681 Reduced 25.2%	94,045 $30.5 Million
Q1 2022 May 12, 2022	SELL	$234.69 - $291.66 $4.04 Million - $5.02 Million	-17,228 Reduced 12.05%	125,726 $36 Million
Q4 2021 Feb 11, 2022	SELL	$224.85 - $279.04 $1.75 Million - $2.17 Million	-7,791 Reduced 5.17%	142,954 $39.5 Million
Q3 2021 Nov 12, 2021	SELL	$221.6 - $272.71 $33,461 - $41,179	-151 Reduced 0.1%	150,745 $34.8 Million
Q2 2021 Aug 09, 2021	BUY	$180.55 - $233.54 $1.72 Million - $2.23 Million	9,531 Added 6.74%	150,896 $34.6 Million
Q1 2021 Apr 30, 2021	SELL	$164.32 - $212.72 $708,712 - $917,461	-4,313 Reduced 2.96%	141,365 $26.4 Million
Q4 2020 Feb 02, 2021	SELL	$130.46 - $172.63 $500,966 - $662,899	-3,840 Reduced 2.57%	145,678 $24.6 Million
Q3 2020 Nov 10, 2020	BUY	$146.22 - $169.13 $1.68 Million - $1.94 Million	11,476 Added 8.31%	149,518 $22.1 Million
Q2 2020 Aug 12, 2020	BUY	$136.42 - $164.18 $5.93 Million - $7.13 Million	43,434 Added 45.91%	138,042 $22.7 Million
Q1 2020 May 13, 2020	SELL	$119.05 - $147.35 $13.1 Million - $16.3 Million	-110,427 Reduced 53.86%	94,608 $13.1 Million
Q4 2019 Feb 12, 2020	SELL	$106.92 - $132.43 $1.37 Million - $1.69 Million	-12,774 Reduced 5.86%	205,035 $26.9 Million
Q3 2019 Nov 14, 2019	SELL	$106.79 - $116.16 $4.5 Million - $4.9 Million	-42,141 Reduced 16.21%	217,809 $24.4 Million
Q2 2019 Aug 12, 2019	SELL	$110.79 - $129.32 $254,373 - $296,918	-2,296 Reduced 0.88%	259,950 $28.8 Million
Q1 2019 May 08, 2019	SELL	$111.31 - $131.02 $8.31 Million - $9.78 Million	-74,648 Reduced 22.16%	262,246 $34 Million
Q4 2018 Feb 13, 2019	BUY	$105.9 - $118.64 $7.92 Million - $8.88 Million	74,808 Added 28.54%	336,894 $39 Million
Q3 2018 Nov 13, 2018	SELL	$85.86 - $107.31 $8.69 Million - $10.9 Million	-101,167 Reduced 27.85%	262,086 $28.1 Million
Q2 2018 Aug 09, 2018	SELL	$75.7 - $86.88 $743,449 - $853,248	-9,821 Reduced 2.63%	363,253 $31 Million
Q1 2018 May 15, 2018	SELL	$74.21 - $87.6 $1.83 Million - $2.16 Million	-24,698 Reduced 6.21%	373,074 $28.9 Million
Q4 2017 Feb 20, 2018	BUY	$81.94 - $87.89 $1.86 Million - $1.99 Million	22,696 Added 6.05%	397,772 $33.6 Million
Q3 2017 Nov 14, 2017	BUY	$77.07 - $85.54 $28.9 Million - $32.1 Million	375,076	375,076 $32.1 Million

Others Institutions Holding LLY

# of Institutions

4,007

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $750B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of British Columbia Investment Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on British Columbia Investment Management Corp with notifications on news.

Account

British Columbia Investment Management Corp Eli Lilly & CO Transaction History